ZA200307306B - Indolines, substituted in portion 6, and their use as kinase inhibitors. - Google Patents

Indolines, substituted in portion 6, and their use as kinase inhibitors.

Info

Publication number
ZA200307306B
ZA200307306B ZA200307306A ZA200307306A ZA200307306B ZA 200307306 B ZA200307306 B ZA 200307306B ZA 200307306 A ZA200307306 A ZA 200307306A ZA 200307306 A ZA200307306 A ZA 200307306A ZA 200307306 B ZA200307306 B ZA 200307306B
Authority
ZA
South Africa
Prior art keywords
indolines
substituted
kinase inhibitors
kinase
inhibitors
Prior art date
Application number
ZA200307306A
Other languages
English (en)
Inventor
Frank Hilberg
Armin Heckel
Thorsten Lehmann-Lintz
Roth Gerald Juergen
Joerg Kley
Jacobus Van Meel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ZA200307306B publication Critical patent/ZA200307306B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200307306A 2001-04-06 2003-09-18 Indolines, substituted in portion 6, and their use as kinase inhibitors. ZA200307306B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10117204A DE10117204A1 (de) 2001-04-06 2001-04-06 In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ZA200307306B true ZA200307306B (en) 2004-08-31

Family

ID=7680648

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200307306A ZA200307306B (en) 2001-04-06 2003-09-18 Indolines, substituted in portion 6, and their use as kinase inhibitors.

Country Status (23)

Country Link
US (1) US6858641B2 (enExample)
EP (1) EP1379501A1 (enExample)
JP (1) JP2004525173A (enExample)
KR (1) KR20030090712A (enExample)
CN (1) CN1509270A (enExample)
AR (1) AR035813A1 (enExample)
BG (1) BG108220A (enExample)
BR (1) BR0208900A (enExample)
CA (1) CA2442695A1 (enExample)
CZ (1) CZ20032975A3 (enExample)
DE (1) DE10117204A1 (enExample)
EA (1) EA200301005A1 (enExample)
EC (1) ECSP034776A (enExample)
EE (1) EE200300491A (enExample)
HU (1) HUP0303737A3 (enExample)
IL (1) IL158254A0 (enExample)
MX (1) MXPA03008896A (enExample)
NO (1) NO20034434D0 (enExample)
PE (1) PE20021058A1 (enExample)
PL (1) PL366458A1 (enExample)
SK (1) SK12412003A3 (enExample)
WO (1) WO2002081445A1 (enExample)
ZA (1) ZA200307306B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10233500A1 (de) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20061155A1 (es) * 2004-12-24 2006-12-16 Boehringer Ingelheim Int Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas
US20060154939A1 (en) * 2004-12-24 2006-07-13 Boehringer Ingelheim International Gmbh Medicaments for the Treatment or Prevention of Fibrotic Diseases
WO2007057397A1 (en) * 2005-11-15 2007-05-24 Boehringer Ingelheim International Gmbh Treatment of cancer
KR20100090772A (ko) 2007-10-12 2010-08-17 인게니움 파르마코이티칼스 게엠베하 단백질 키나제 억제제
UY31506A1 (es) 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
EP2303841A1 (en) * 2008-07-14 2011-04-06 Gilead Sciences, Inc. Oxindolyl inhibitor compounds
US8853420B2 (en) 2008-07-29 2014-10-07 Boehringer Ingelheim International Gmbh Compounds
EA201201274A1 (ru) 2010-03-10 2013-04-30 Инджениум Фармасьютиклз Гмбх Ингибиторы протеинкиназ
CN102267934B (zh) * 2010-06-02 2013-04-17 金凯美(大连)医药科技有限公司 一种6-甲氧羰基吲哚酮的制备方法
HRP20230833T1 (hr) * 2015-12-24 2023-11-10 Respivert Limited Spojevi indolinona i njihova uporaba u liječenju fibroznih bolesti
EP3426649B1 (en) * 2016-03-08 2020-07-22 Respivert Limited Indole derivatives and their use as protein kinase inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE308520T1 (de) * 1996-08-23 2005-11-15 Sugen Inc Kombinatorische bibliotheken von indolinone und verwandte produkte und verfahren zur behandlung von krankheiten
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6043254A (en) * 1998-04-03 2000-03-28 Boehringer Ingelheim Pharma Kg Indolinones having kinase-inhibiting activity
US6169106B1 (en) * 1998-04-15 2001-01-02 Boehringer Ingelheim Pharma Kg Indolinones having kinase inhibitory activity
DE19816624A1 (de) 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE19824922A1 (de) 1998-06-04 1999-12-09 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6319918B1 (en) * 1998-06-04 2001-11-20 Boehringer Ingelheim Pharma Kg Substituted indolinones with kinase inhibitory activity
DE19924401A1 (de) 1999-05-27 2000-11-30 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6794395B1 (en) 1999-08-27 2004-09-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituted indolinones, their manufacture and their use as medicaments
DE19940829A1 (de) 1999-08-27 2001-03-01 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
UA75054C2 (uk) 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
DE10042696A1 (de) 2000-08-31 2002-03-14 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
EP1379501A1 (de) 2004-01-14
PE20021058A1 (es) 2003-01-20
CZ20032975A3 (cs) 2004-02-18
MXPA03008896A (es) 2003-12-08
NO20034434L (no) 2003-10-03
CN1509270A (zh) 2004-06-30
JP2004525173A (ja) 2004-08-19
HUP0303737A3 (en) 2004-09-28
NO20034434D0 (no) 2003-10-03
EA200301005A1 (ru) 2004-04-29
PL366458A1 (en) 2005-02-07
SK12412003A3 (sk) 2004-04-06
EE200300491A (et) 2004-02-16
KR20030090712A (ko) 2003-11-28
CA2442695A1 (en) 2002-10-17
HUP0303737A2 (hu) 2004-03-01
ECSP034776A (es) 2003-12-01
BR0208900A (pt) 2004-04-20
AR035813A1 (es) 2004-07-14
DE10117204A1 (de) 2002-10-10
WO2002081445A1 (de) 2002-10-17
US6858641B2 (en) 2005-02-22
IL158254A0 (en) 2004-05-12
US20030092756A1 (en) 2003-05-15
BG108220A (bg) 2004-09-30

Similar Documents

Publication Publication Date Title
AU2002362895A1 (en) 5-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
AP2003002857A0 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors.
AU2002346929A1 (en) 5-acylamino-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
ZA200206386B (en) Kinase inhibitors.
ZA200202985B (en) Tyrosine kinase inhibitors.
MXPA03005713A (es) Derivados de tetrahidropiridina, su preparacion y su uso como inhibidores de proliferacion celular.
MXPA03009220A (es) Derivados de bipiperidinilo y su uso como inhibidores de receptores de quimiocina.
MXPA03005298A (es) Inhibidores de girasa y usos de los mismos.
AU2001251063A1 (en) 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
IL162266A (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the use of the same
MXPA03008690A (es) Inhibidores novedosos de tirosina cinasa.
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
IL166100A0 (en) 7,8,9-10-tetrahydro-6h-azepino,6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrroloÄ2,1-bÜ quinazolinone derivatives
ZA200108291B (en) Diaminothiazoles and their use for inhibiting protein kinases.
AP2004003161A0 (en) Substituted benzazoles and use thereof as raf kinase inhibitors.
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
MXPA03003314A (es) Compuestos de c-nitrosoanilina y sus mezclas como inhibidores de polimerizacion.
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
AU2002359126A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
ZA200307306B (en) Indolines, substituted in portion 6, and their use as kinase inhibitors.
NO20015062D0 (no) Substituerte 3-cyano-[1.7],[1.5]og[1.8]-naftyridin- inhibitorer for tyrosin-kinaser
HUP0303034A3 (en) Novel 7-azaindole-derivatives, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
MXPA03001557A (es) Derivados bifenilo.